These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. BGG492 as an adjunctive treatment in patients with partial-onset seizures: A 12-week, randomized, double-blind, placebo-controlled, phase II dose-titration study with an open-label extension. Elger CE; Hong SB; Brandt C; Mancione L; Han J; Strohmaier C Epilepsia; 2017 Jul; 58(7):1217-1226. PubMed ID: 28500678 [TBL] [Abstract][Full Text] [Related]
4. Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks. Gomez-Mancilla B; Brand R; Jürgens TP; Göbel H; Sommer C; Straube A; Evers S; Sommer M; Campos V; Kalkman HO; Hariry S; Pezous N; Johns D; Diener HC; Cephalalgia; 2014 Feb; 34(2):103-13. PubMed ID: 23963355 [TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled phase 2 study of intratympanic OTO-313 in patients with moderate to severe subjective tinnitus. Searchfield GD; Robinson JM; Skarinsky D; Wang Y; Anderson JJ Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5307-5318. PubMed ID: 37341760 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus. Suckfüll M; Althaus M; Ellers-Lenz B; Gebauer A; Görtelmeyer R; Jastreboff PJ; Moebius HJ; Rosenberg T; Russ H; Wirth Y; Krueger H BMC Ear Nose Throat Disord; 2011 Jan; 11():1. PubMed ID: 21223542 [TBL] [Abstract][Full Text] [Related]
7. Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study. Maxwell KS; Robinson JM; Hoffmann I; Hou HJ; Searchfield G; Baguley DM; McMurry G; Piu F; Anderson JJ Otol Neurotol; 2021 Dec; 42(10):e1625-e1633. PubMed ID: 34629442 [TBL] [Abstract][Full Text] [Related]
8. BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy. Faught E Expert Opin Investig Drugs; 2014 Jan; 23(1):107-13. PubMed ID: 24147649 [TBL] [Abstract][Full Text] [Related]
9. Effect of a 4-Week Treatment with Cilostazol in Patients with Chronic Tinnitus: A Randomized, Prospective, Placebo-controlled, Double-blind, Pilot Study. Lim HW; Kim TS; Kang WS; Song CI; Baek S; Chung JW J Int Adv Otol; 2016 Aug; 12(2):170-176. PubMed ID: 27716604 [TBL] [Abstract][Full Text] [Related]
10. A Randomized, Placebo-Controlled, Double-Blind, Parallel Groups Study Evaluating the Performance and Safety of a Steady State Coherent Biomodulator Patch in the Treatment of Subjective Tinnitus. Ahnblad P; Nordkvist A Int Tinnitus J; 2017 Dec; 21(2):157-167. PubMed ID: 29336135 [TBL] [Abstract][Full Text] [Related]
11. [A double-blind randomized controlled trial on the efficacy of mixed pure tone sound therapy in chronic tinnitus patients with different hearing loss]. Li Y; Feng GD; Wu HY; Gao ZQ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 54(5):355-361. PubMed ID: 31137095 [No Abstract] [Full Text] [Related]
12. Efficacy and safety of AM-101 in the treatment of acute inner ear tinnitus--a double-blind, randomized, placebo-controlled phase II study. van de Heyning P; Muehlmeier G; Cox T; Lisowska G; Maier H; Morawski K; Meyer T Otol Neurotol; 2014 Apr; 35(4):589-97. PubMed ID: 24603353 [TBL] [Abstract][Full Text] [Related]
14. The effects of sertraline on severe tinnitus suffering--a randomized, double-blind, placebo-controlled study. Zöger S; Svedlund J; Holgers KM J Clin Psychopharmacol; 2006 Feb; 26(1):32-9. PubMed ID: 16415703 [TBL] [Abstract][Full Text] [Related]
15. Clinical effect of intratympanic dexamethasone injection in acute unilateral tinnitus: A prospective, placebo-controlled, multicenter study. Lee HJ; Kim MB; Yoo SY; Park SN; Nam EC; Moon IS; Lee HK Laryngoscope; 2018 Jan; 128(1):184-188. PubMed ID: 28224644 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness of transmeatal low-power laser stimulation in treating tinnitus. Ngao CF; Tan TS; Narayanan P; Raman R Eur Arch Otorhinolaryngol; 2014 May; 271(5):975-80. PubMed ID: 23605244 [TBL] [Abstract][Full Text] [Related]
17. A preliminary study on the efficacy and safety of low level light therapy in the management of cochlear tinnitus: A single blind randomized clinical trial. Choi JE; Lee MY; Chung PS; Jung JY Int Tinnitus J; 2019 Jan; 23(1):52-57. PubMed ID: 31469529 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Trimetazidine Dihydrochloride for Relieving Chronic Tinnitus: A Randomized Double-Blind Study. Kumral TL; Yıldırım G; Berkiten G; Saltürk Z; Ataç E; Atar Y; Uyar Y Clin Exp Otorhinolaryngol; 2016 Sep; 9(3):192-7. PubMed ID: 27230273 [TBL] [Abstract][Full Text] [Related]
19. The low-power laser in the treatment of tinnitus. Mirz F; Zachariae R; Andersen SE; Nielsen AG; Johansen LV; Bjerring P; Pedersen CB Clin Otolaryngol Allied Sci; 1999 Aug; 24(4):346-54. PubMed ID: 10472473 [TBL] [Abstract][Full Text] [Related]
20. Psychometric evaluation of visual analog scale for the assessment of chronic tinnitus. Adamchic I; Langguth B; Hauptmann C; Tass PA Am J Audiol; 2012 Dec; 21(2):215-25. PubMed ID: 22846637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]